ENTITY

Immutep (IMM AU)

27
Analysis
Health CareAustralia
Immutep Limited operates as a biotechnology company. The Company focuses on developing novel immunotherapy treatments for cancer and autoimmune disease. Immutep offers its services worldwide.
more
bullishTelstra Corp
18 May 2026 06:10

Aussie Shorts [11 May 2026]: Telstra, Woolworths, Lotus Res., Arafura Res., Mcmillan Shakespeare

The largest industry net increase in the past week was A$1.6bn into "Diversified Meals"; the largest industry net decrease was A$129mn out of...

Logo
82 Views
Share
16 Jul 2024 23:44

Australian Biotech Companies Amid Talk of Likely Interest Rate Cut

​RBA keeps interest rates steady at 4.35%, while economists predict possible cut to 4.10% in 4Q24. Australian biotech companies should be in focus...

Logo
439 Views
Share
bullishGoodman Fielder
23 Mar 2026 06:10

Aussie Shorts (16th Mar 2026): Goodman Fielder, Woodside Petroleum, TPG Telecom, DroneShield

The largest industry net increase in the past week was into "Diversified Banks"; the largest industry net decrease was out of "Industrial REITs"....

Logo
357 Views
Share
19 Mar 2026 20:31

ASX Short Interest Weekly (Mar 13th): Insurance Australia, CSL, Transurban, James Hardie Industries

We analyzed ASX short interest report for the past week and highlight short interest changes in Insurance Australia, CSL, Transurban, James Hardie...

Logo
182 Views
Share
bearishMacroeconomics
01 Apr 2015 11:31

Taxing Times For Australia

The Government's release of Re:think, its tax discussion paper, is a welcome development, designed to kick-start the conversation with the...

Logo
6.1k Views
Share
x